跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
芮达 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Paliperidone Extended-Release Tablets
Approved
化学药品
Paliperidone Extended-Release Tablets
Janssen-Cilag International NV
🇨🇳 National Medical Products Administration
Approval Date
Oct 10, 2021
Approval ID
8DqlgnLjF1N
Company
Janssen-Cilag International NV
Type
化学药品
Approval Details
Approval Id
8DqlgnLjF1N
Approval Number
国药准字HJ20160552
Generic Name
帕利哌酮缓释片
Generic Name En
Paliperidone Extended-Release Tablets
Trade Name
芮达
Drug Type
化学药品
Dosage Form
片剂
Strength
3mg
Reg Date
2021-10-10
Expired Date
2026-10-09
Company Name
Janssen-Cilag International NV
Company Detail Path
/organization/janssen-cilag-international-nv
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 10, 2021
Approval ID
8DqlgnLjF1N
Type
化学药品
Back to NMPA Approvals